Eye Care Center
Maadi, Cairo Governorate, Egypt
NCT Number: NCT05406973
LASIK is the most commonly performed refractive surgery worldwide. It has been shown to be safe and effective procedure with predictable results over long term follow ups. With the advancement of technology, sub-Bowman keratomileusis allows thin flap of approximately 100 microns thickness thus preserving thicker stromal bed as compared to conventional LASIK. The femtosecond laser corneal flap has th advantage of producing a flap of uniform thickness, adjustable flap diameter, relatively few complications. The disadvantages of this procedure is the high cost of surgery, development of bubbles in the corneal layer and anterior chamber which may affect pupil trackingduring the procedure. Despite the emergence of femtosecond laser-assisted flap creation, mechanical microkeratomes remain the preferred choice in the majority of developing countries. Recent studies have shown that SBK corneal flap has the same advantages as femtosecond laser flap regarding flap uniformity, regularity, and accuracy with less suction time and cost, but with its specific complications as well.
Looking for future studies?
Notify Me20 year–40 year
All sexes
Interventional
Not applicable
Maadi, Cairo Governorate, Egypt
It is a prospective comparative non randomized interventional clinical study
Primary outcomes of this study include:
Secondary outcomes:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
prospective comparative non randomized interventional clinical study
Time frame: 1 month post operative
comparison between the accuracy of the SBK microkeratome versus Femtosecond laser in flap creation during LASIK surgery for myopia, 1 month after surgery using anterior segment OCT
Time frame: 1day, 1 week, 1 month after surgery
measuring UCVA and BCVA
Kasr El Aini Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06818461
Corneal Diseases, Eye Diseases
Mohandessin, Giza Governorate, Egypt
View Trial DetailsNCT03569423
Eye Diseases, Myopia
Al Minyā, Egypt
View Trial DetailsNCT07544615
Astigmatism, Eye Diseases
Tianjin, Tianjin Municipality, China
View Trial DetailsNCT04396990
Refractive Surgery
Sioux Falls, South Dakota, United States
View Trial Details